Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Lymphedema 1Head and Neck Neoplasms 1Breast Cancer Lymphedema 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
carbohydrate-deficient transferrin × 1 year × Clear all
NCT05182229 2026-05-06

Comparing Two Ways to Manage Head and Neck Lymphedema

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
240 enrolled
Head & Neck

Head and Neck Neoplasms, Lymphedema

NCT07154043 2026-03-04

Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

Pamukkale University

Phase NA Recruiting
45 enrolled
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡